Pancreatic Cancer Research

ResearcherZhejiang Chinese Medical UniversityNo recent work listed

Mengru Lai

Matched on ORCID iD 0000-0003-0742-022X; OpenAlex author ID A5035952639.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers
2 (first author 1, last author 0)
Pancreatic cancer trials
0
Pancreatic cancer grants
0
Collaborators
3
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper

Papers 2

  1. Saikosaponin D Inhibits Proliferation and Promotes Apoptosis Through Activation of MKK4-JNK Signaling Pathway in Pancreatic Cancer Cells. First author DOI 10.2147/ott.s263322↗
  2. [Current status and future prospect of pharmacotherapy for pancreatic cancer]. Co-author DOI 10.19540/j.cnki.cjcmm.20190104.002↗

Closest collaborators

The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Yuqing Ge · 2 shared papers, 2019–2020
  2. Rubin Cheng · 2 shared papers, 2019–2020
  3. Yun Fang Ma · 1 shared paper, 2019

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.